SomnoMed Ltd (ASX: SOM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

SomnoMed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $142.30 million
P/E Ratio 136.99
Dividend Yield 0.00%
Shares Outstanding 218.44 million
Earnings per share -0.012
Dividend per share N/A
Year To Date Return -18.45%
Earnings Yield 0.73%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

SomnoMed Ltd (ASX: SOM)
Latest News

a woman
⏸️ Investing

Is Somnomed Limited a better buy than ResMed Inc. (CHESS)?

Somnomed Limited (ASX:SOM) has the potential to grow at the expense of ResMed Inc. (CHESS) (ASX:RMD) and Fisher & Paykel…

Read more »

a woman
⏸️ Investing

Who else wants 5 bargain small-cap stocks?

The small-cap end of town is hiding some truly great stocks such as Senetas Corporation Limited (ASX:SEN), AMA Group Ltd…

Read more »

a woman
⏸️ Investing

Somnomed Limited downgrades guidance: Is now the time to buy?

Somnomed Limited (ASX:SOM) is competing with ResMed Inc. (CHESS) (ASX:RMD) for growth in the sleep-disorder market.

Read more »

a woman
⏸️ Investing

9 juicy health care stocks to add to your portfolio: Part 1

Health care is one big trend which could be hugely profitable. Here are 4 health care stock ideas to consider

Read more »

a woman
⏸️ Investing

Here's why these 4 stocks smashed the market today

Financial services stocks with global exposure like Platinum Asset Management Limited (ASX:PTM) and Magellan Financial Group Ltd (ASX:MFG) continue to…

Read more »

⏸️ Investing

Here's why these 4 stocks are soaring higher today

Qantas Airways Limited (ASX:QAN) and Insurance Australia Group Ltd (ASX:IAG) have started the trading week on fire.

Read more »

⏸️ Investing

5 ASX stocks smashing the market today

The market might be down, but these 5 stocks are rocketing up

Read more »

a woman
⏸️ Investing

Here's why these 3 stocks have been rocketing higher today

The key to making big returns is finding the growth businesses of tomorrow and these three might just be the…

Read more »

a woman
⏸️ Investing

Is Somnonmed Limited plotting a path to blockbuster success?

This medical business could be one of the best stocks of the next decade.

Read more »

a woman
⏸️ Investing

Are Somnomed Limited shareholders on the road to riches?

Somnomed (ASX:SOM) is a microcap company in the same business as ResMed Inc. (CHESS) (ASX:RMD). But how much longer will…

Read more »

⏸️ Investing

Is Somnomed Limited a better buy than ResMed Inc?

This little pocket rocket of a company is up over 50% in the last year alone...

Read more »

a woman
⏸️ Investing

3 tailwind stocks for powerful returns

If I didn't already own these three top notch companies, I'd be placing an order today!

Read more »

SOM ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About SomnoMed Ltd

SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devicesfor sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

SOM Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
24 Mar 2026 $0.65 $0.02 3.17% 28,070 $0.65 $0.65 $0.64
23 Mar 2026 $0.63 $-0.01 -1.57% 33,910 $0.60 $0.63 $0.60
20 Mar 2026 $0.64 $-0.03 -4.48% 28,642 $0.65 $0.65 $0.64
19 Mar 2026 $0.67 $0.01 1.50% 79,296 $0.68 $0.68 $0.67
18 Mar 2026 $0.67 $0.03 4.69% 24,266 $0.64 $0.67 $0.64
17 Mar 2026 $0.64 $0.01 1.57% 71,936 $0.65 $0.66 $0.62
16 Mar 2026 $0.64 $-0.03 -4.55% 19,674 $0.66 $0.66 $0.64
13 Mar 2026 $0.66 $0.00 0.00% 24,159 $0.66 $0.66 $0.66
12 Mar 2026 $0.66 $-0.03 -4.35% 491 $0.66 $0.66 $0.66
11 Mar 2026 $0.69 $0.04 6.15% 25,085 $0.70 $0.70 $0.69
10 Mar 2026 $0.65 $0.00 0.00% 9,855 $0.65 $0.68 $0.65
09 Mar 2026 $0.65 $-0.03 -4.44% 356,367 $0.68 $0.68 $0.65
06 Mar 2026 $0.68 $-0.02 -2.86% 2,256 $0.70 $0.70 $0.67
05 Mar 2026 $0.70 $0.03 4.48% 63,067 $0.67 $0.74 $0.67
04 Mar 2026 $0.67 $-0.02 -2.90% 222,477 $0.68 $0.68 $0.60
03 Mar 2026 $0.69 $-0.03 -4.20% 61,799 $0.70 $0.71 $0.69
02 Mar 2026 $0.72 $-0.02 -2.74% 34,344 $0.73 $0.73 $0.70
27 Feb 2026 $0.73 $0.07 10.61% 49,166 $0.68 $0.79 $0.68
25 Feb 2026 $0.66 $-0.03 -4.35% 9,347 $0.66 $0.66 $0.66
24 Feb 2026 $0.69 $-0.02 -2.84% 20,794 $0.70 $0.70 $0.66

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
04 Dec 2025 Michael Gordon Issued 200,000 $160,000
Issue of options.
04 Dec 2025 Gaetano (Guy) Russo Issued 600,000 $480,000
Issue of options.
04 Dec 2025 Andrew Price Issued 300,000 $240,000
Issue of options.
04 Dec 2025 Benjamin(Ben) Gisz Issued 200,000 $160,000
Issue of options. As per announcement
04 Dec 2025 Amrita Blickstead Issued 1,700,000 $1,360,000
Issue of options.
04 Dec 2025 Karen Borg Issued 1,700,000 $1,360,000
Issue of options.
16 Sep 2025 Benjamin(Ben) Gisz Sell 13,211,430 $9,248,001
On-market trade.
06 Aug 2025 Amrita Blickstead Exercise 1,325,000 $1,040,125
Exercise of options.
06 Aug 2025 Amrita Blickstead Issued 1,325,000 $1,040,125
Exercise of options.
06 Aug 2025 Karen Borg Exercise 750,000 $588,750
Exercise of options.
06 Aug 2025 Karen Borg Issued 750,000 $588,750
Exercise of options.
01 Jul 2025 Karen Borg Issued 600,000 $384,000
Issue of options.
01 Jul 2025 Amrita Blickstead Issued 600,000 $384,000
Issue of options.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael Gordon Non-Executive Director Aug 2020
Mr Gordon is the Director of Koala Company Limited, a direct-to-consumer household goods retailer. Michael was previously the CFO of Rokt, a marketing technology company, and CFO of Different Technologies, a property technology company. Prior to these, Michael was the Group CFO and MD Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Michael started his career with PricewaterhouseCoopers, spending 10 years with them in South Africa, the United Kingdom and Australia specializing in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is a Chairman of the Risk Committee.
Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
Mr Russo has a commercial and customer-focused background working in Australia and internationally. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He has been a member of YPO since 2006, served as a member of the Business Council of Australia.
Mr Andrew Price Non-Executive Director Jan 2025
Mr Price is an executive in the medical device industry, has spent the last 25 years at ResMed in various senior roles. Prior to finishing his employment with ResMed, Andrew was Chief Supply Chain Officer, leading all functions of the end-to-end supply chain including supplier management, manufacturing, logistics, distribution, quality assurance and regulatory affairs. Andrew held roles at ResMed across product development, project management and business development globally. He is a member of the Risk Committee.
Mr Benjamin(Ben) Gisz Non-Executive Director Oct 2024
Mr Gisz is a director and member of the investment team at TDM Growth Partners, an investment firm specializing in long-term investments in high-growth companies globally. Ben has investment, corporate advisory and financial markets experience, including prior roles with Investec Group and Credit Suisse. Ben is a current Non-Executive Director at Australian pet supplies ecommerce business Pet Circle. He is a member of Risk Committee.
Ms Amrita Blickstead Executive DirectorJoint CEO Feb 2024
Mr Blickstead was the Chief Operating and Marketing Officer at eBay Australia & New Zealand, where she led business areas across strategy, operations, marketing, sales, and pricing over her ten-year tenure. Prior to these executive roles, Amrita built her foundation as a Management Consultant and a Biomedical Engineer.
Ms Karen Borg Executive DirectorJoint CEO Feb 2024
Ms Borg has held senior roles in FTSE 100-250 medical devices, technology, consumer products and government services organizations. Karen was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Karen began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing. Karen is on the Board of KOPWA Aged Care Services and was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance.
Mr Terence Anthony Flitcroft Company Secretary
-
Ye-Fei Guo Chief Financial Officer
-
Terence Anthony Flitcroft Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 110,635,851 51.20%
J P Morgan Nominees Australia Pty Limited 11,013,948 5.10%
Dottie Investments Pty Ltd 9,166,619 4.24%
Mutual Trust Pty Ltd 7,746,054 3.58%
Howarth PAF Pty Ltd <The Howarth Foundation A/C> 5,415,675 2.51%
Equity Plan Services Pty Ltd 4,582,482 2.12%
BNP Paribas Nominees Pty Ltd <Clearstream> 4,287,467 1.98%
Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> 3,100,000 1.43%
Timbina Pty Limited <Timbina Super Fund A/C> 2,696,297 1.25%
Ginga Pty Ltd 2,444,216 1.13%
Ginga Pty Ltd <TG Klinger S/F A/C> 2,367,685 1.10%
P Neustadt Holdings Pty Limited <Belgove Super Fund A/C> 2,353,628 1.09%
Mr Gaetano Alfred Gerrard <Rusbev Super FD A/C> 2,055,220 0.95%
Belgove Pty Ltd 1,853,265 0.86%
Golden Words Pty Ltd 1,650,419 0.76%
Dinwoodie Investments Pty Ltd 1,584,612 0.73%
REM Medical Pty Ltd <Cocoon Super Fund A/C> 1,342,801 0.62%
Howarth PAF Pty Limited <Howarth Charitable Fund A/C> 1,315,225 0.61%
Howarth Commercial Pty Limited 1,174,670 0.54%
Dinwoodie Investments Pty Ltd <Dinwoodie Investments A/C> 1,164,286 0.55%

Profile

since

Note